$19.16
0.21%
Nasdaq, Oct 02, 04:04 pm EDT.
ISIN
US78573L1061
Symbol
SBRA

Sabra Health Care REIT, Inc. Target price 2026 - Analyst rating & recommendation

Sabra Health Care REIT, Inc. Classifications & Recommendation

Buy
50%
Hold
50%

Sabra Health Care REIT, Inc. Price Target

Target Price $23.46
Price $19.16
Potential
Number of Estimates 16
16 Analysts have issued a price target Sabra Health Care REIT, Inc. 2027 . The average Sabra Health Care REIT, Inc. target price is $23.46. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 22 analysts: 11 Analysts recommend Sabra Health Care REIT, Inc. to buy, 11 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Sabra Health Care REIT, Inc. stock has an average upside potential 2027 of . Most analysts recommend the Sabra Health Care REIT, Inc. stock at Buy or hold.

Sales and Margin forecast 2026, 2027 to 2031

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 774.63 926.68
10.15% 19.63%
EBITDA Margin 58.20% 55.90%
4.06% 3.96%
Net Margin 20.09% 16.00%
11.49% 20.35%

15 Analysts have issued a sales forecast Sabra Health Care REIT, Inc. 2026 . The average Sabra Health Care REIT, Inc. sales estimate is

$927m
unlock
. This is
7.81% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$991m 15.31%
unlock
, the lowest is
$848m 1.39%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $775m 10.15%
2026
$927m 19.63%
unlock
2027
$1.0b 10.39%
unlock
2028
$1.1b 11.05%
unlock
2029
$1.3b 13.38%
unlock
2030
$1.4b 8.62%
unlock
2031
$1.5b 10.01%
unlock

14 Analysts have issued an Sabra Health Care REIT, Inc. EBITDA forecast 2026. The average Sabra Health Care REIT, Inc. EBITDA estimate is

$518m
unlock
. This is
40.06% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$552m 49.22%
unlock
, the lowest is
$437m 18.26%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $451m 5.67%
2026
$518m 14.89%
unlock
2027
$574m 10.90%
unlock
2028
$613m 6.67%
unlock
2029
$564m 7.92%
unlock

EBITDA Margin

2025 58.20% 4.06%
2026
55.90% 3.96%
unlock
2027
56.15% 0.45%
unlock
2028
53.94% 3.94%
unlock

12 Sabra Health Care REIT, Inc. Analysts have issued a net profit forecast 2026. The average Sabra Health Care REIT, Inc. net profit estimate is

$148m
unlock
. This is
126.56% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$201m 207.41%
unlock
, the lowest is
$97.6m 49.21%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $156m 22.81%
2026
$148m 4.72%
unlock
2027
$196m 32.34%
unlock
2028
$205m 4.69%
unlock

Net Margin

2025 20.09% 11.49%
2026
16.00% 20.35%
unlock
2027
19.18% 19.88%
unlock
2028
18.08% 5.74%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2031

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ 0.64 0.58
18.52% 9.38%
P/E 33.01
EV/Sales 7.87

12 Analysts have issued a Sabra Health Care REIT, Inc. forecast for earnings per share. The average Sabra Health Care REIT, Inc. EPS is

$0.58
unlock
. This is
123.08% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$0.79 203.85%
unlock
, the lowest is
$0.38 46.15%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $0.64 18.52%
2026
$0.58 9.38%
unlock
2027
$0.77 32.76%
unlock
2028
$0.80 3.90%
unlock

P/E ratio

Current 73.69 197.43%
2026
33.01 55.21%
unlock
2027
24.95 24.42%
unlock
2028
23.83 4.49%
unlock

Based on analysts' sales estimates for 2026, the Sabra Health Care REIT, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 8.48 9.40%
2026
7.87 7.24%
unlock
2027
7.13 9.42%
unlock
2028
6.42 9.95%
unlock
2029
5.66 11.80%
unlock
2030
5.21 7.94%
unlock
2031
4.74 9.10%
unlock

P/S ratio

Current 5.69 6.76%
2026
5.28 7.24%
unlock
2027
4.78 9.42%
unlock
2028
4.31 9.95%
unlock
2029
3.80 11.80%
unlock
2030
3.50 7.93%
unlock
2031
3.18 9.10%
unlock

Current Sabra Health Care REIT, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Baird
Locked
➜
Locked
Locked Aug 31 2026
Barclays
Locked
➜
Locked
Locked Aug 31 2026
Raymond James
Locked
➜
Locked
Locked Aug 06 2026
Baird
Locked
➜
Locked
Locked Jul 22 2026
Truist Securities
Locked
➜
Locked
Locked Jul 22 2026
Citizens
Locked
➜
Locked
Locked Jul 22 2026
Truist Securities
Locked
➜
Locked
Locked Jul 08 2026
Analyst Rating Date
Locked
Baird:
Locked
➜
Locked
Aug 31 2026
Locked
Barclays:
Locked
➜
Locked
Aug 31 2026
Locked
Raymond James:
Locked
➜
Locked
Aug 06 2026
Locked
Baird:
Locked
➜
Locked
Jul 22 2026
Locked
Truist Securities:
Locked
➜
Locked
Jul 22 2026
Locked
Citizens:
Locked
➜
Locked
Jul 22 2026
Locked
Truist Securities:
Locked
➜
Locked
Jul 08 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today